Skip to main content

Bio-Techne Corporation

corporate_fare Company Profile

Bio-Techne Corporation

TECH·NASDAQ·Life Sciences·CIK 0000842023

Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. Its product portfolio and application expertise support scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. Its products aid drug discovery efforts and provide the means for accurate clinical tests and diagnoses. The company manages its business in two operating segments. The Protein Sciences segment is a leading developer and manufacturer of high-quality biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for protein analysis, automated western blot, and multiplexed ELISA workflows. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications. Bio-Techne is a Minnesota corporation with its global headquarters in Minneapolis, Minnesota. It was founded in 1976 as Research and Diagnostic Systems, Inc. and became a publicly traded company in 1985 through a merger with Techne Corporation, now Bio-Techne Corporation. Its common stock is listed on the NASDAQ under the symbol "TECH." The company operates globally, with offices in many locations throughout North America, Europe and Asia. Its product lines include hundreds of thousands of diverse products, most of which it manufactures itself in multiple locations in North America, as well as locations in the U.K., Canada, Switzerland and China. It has implemented a disciplined strategy to accelerate growth in part by acquiring businesses and product portfolios that leveraged and diversified its existing product lines, filled portfolio gaps with differentiated high growth businesses, and expanded its geographic scope.

Bio-Techne Corporation (NASDAQ:TECH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 20 items for TECH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-23, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 11 rated 8 or above. Recent SEC coverage for TECH spans 8-K, DEFA14A, 10-K, DEFM14A.

Recent high-impact activity:

  • Shareholders Overwhelmingly Back Bio-Techne's $73/Share Sale to Merck KGaA
  • Bio-Techne Shareholders Approve $73/Share Merck KGaA Acquisition
  • Bio-Techne Supplements Proxy With Goldman Valuation Details Amid Shareholder Lawsuit
  • Bio-Techne Discloses Shareholder Lawsuit Seeking to Block Merck Vote
  • Bio-Techne FY2026 10-K: Flat Sales, 148% GAAP EPS Jump, and a $1B Wilson Wolf Obligation

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$1.22B
Net Income
$181.86M
Diluted EPS
$1.16
Op. Cash Flow
$292.07M
Free Cash Flow
$263.22M
Gross Profit
$799.07M
Operating Income
$251.89M
Cash & Equivalents
$264.71M
Debt / Equity
0.00×
Net Margin
15.0%
Shares Outstanding
156.1M sh
Source: 10-K · filed 2026-08-24 · accession 0001104659-26-100322

Short Interest & Short Volume

2.73 days to cover

FINRA reported short interest of 7,703,626 shares in TECH as of the October 30, 2026 settlement, a 2.0% increase from the prior period — about 2.7 days to cover at its recent average daily volume. On November 20, 2026, 42.5% of TECH volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)7,703,626 shares as of October 30, 2026
Change vs prior period▲ 2.0%
Days to cover2.73 at avg daily volume of 2,824,318
Daily short volume (FINRA facilities)42.5% of 915,772 shares on November 20, 2026
5-day average short volume35.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with T →
$72.69 +0.03% today
52-week range · as of 2026-09-23 $43.2 – $72.69
Market cap
$11.42B
Volume
3.7M (1.2× avg)
3-mo avg 3M
Live data · 2026-11-21 07:34 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TECH - Latest Insights

TECH
Sep 23, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $72.52
Real-time Price: $72.70 info
Change: +$0.175 (+0.24%) info
Market Cap: $11.416B info
TECH
Sep 23, 2026, 9:20 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $72.55
Real-time Price: $72.70 info
Change: +$0.145 (+0.20%) info
Market Cap: $11.416B info
TECH
Sep 14, 2026, 4:47 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $72.29
Real-time Price: $72.70 info
Change: +$0.405 (+0.56%) info
Market Cap: $11.416B info
TECH
Sep 14, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $72.29
Real-time Price: $72.70 info
Change: +$0.405 (+0.56%) info
Market Cap: $11.416B info
TECH
Aug 24, 2026, 4:31 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $72.33
Real-time Price: $72.70 info
Change: +$0.365 (+0.50%) info
Market Cap: $11.416B info
TECH
Aug 20, 2026, 5:19 PM EDT
Filing Type: DEFM14A
Importance Score:
7
Price at Filing: $72.28
Real-time Price: $72.70 info
Change: +$0.415 (+0.57%) info
Market Cap: $11.416B info
TECH
Aug 17, 2026, 6:29 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $71.40
Real-time Price: $72.70 info
Change: +$1.29 (+2%) info
Market Cap: $11.416B info
TECH
Aug 12, 2026, 6:38 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $72.20
Real-time Price: $72.70 info
Change: +$0.495 (+0.69%) info
Market Cap: $11.416B info
TECH
Aug 10, 2026, 4:34 PM EDT
Filing Type: PREM14A
Importance Score:
9
Price at Filing: $72.10
Real-time Price: $72.70 info
Change: +$0.595 (+0.83%) info
Market Cap: $11.416B info
TECH
Jul 09, 2026, 4:19 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $71.15
Real-time Price: $72.70 info
Change: +$1.54 (+2%) info
Market Cap: $11.416B info
TECH
Jun 27, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $70.50
Real-time Price: $72.70 info
Change: +$2.19 (+3%) info
Market Cap: $11.416B info
TECH
Jun 25, 2026, 6:49 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $71.06
Real-time Price: $72.70 info
Change: +$1.63 (+2%) info
Market Cap: $11.416B info
TECH
Jun 25, 2026, 4:46 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $70.94
Real-time Price: $72.70 info
Change: +$1.75 (+2%) info
Market Cap: $11.416B info
TECH
Jun 25, 2026, 8:21 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $70.40
Real-time Price: $72.70 info
Change: +$2.29 (+3%) info
Market Cap: $11.416B info
TECH
Jun 25, 2026, 5:35 AM EDT
Source: Dow Jones Newswires
Importance Score:
10
Price at Filing: $69.00
Real-time Price: $72.70 info
Change: +$3.69 (+5%) info
Market Cap: $11.416B info
TECH
Jun 15, 2026, 8:46 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $55.38
Real-time Price: $72.70 info
Change: +$17.31 (+31%) info
Market Cap: $11.416B info
TECH
May 06, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $47.51
Real-time Price: $72.70 info
Change: +$25.18 (+53%) info
Market Cap: $11.416B info
TECH
May 06, 2026, 7:20 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $56.68
Real-time Price: $72.70 info
Change: +$16.01 (+28%) info
Market Cap: $11.416B info
TECH
Feb 11, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $63.45
Real-time Price: $72.70 info
Change: +$9.24 (+15%) info
Market Cap: $11.416B info
TECH
Feb 04, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $68.67
Real-time Price: $72.70 info
Change: +$4.02 (+6%) info
Market Cap: $11.416B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets